USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) Director Gilbert A. Fuller sold 674 shares of the company's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $31.44, for a total value of $21,190.56. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
USANA Health Sciences Stock Up 0.7 %
NYSE USNA opened at $33.18 on Tuesday. The firm has a market cap of $632.47 million, a price-to-earnings ratio of 11.73, a price-to-earnings-growth ratio of 0.93 and a beta of 0.98. The business has a 50-day moving average price of $32.96 and a 200-day moving average price of $36.18. USANA Health Sciences, Inc. has a twelve month low of $27.71 and a twelve month high of $50.32.
USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping analysts' consensus estimates of $0.49 by $0.15. The company had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. Research analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.
Institutional Investors Weigh In On USANA Health Sciences
A number of hedge funds have recently made changes to their positions in the company. Martingale Asset Management L P lifted its position in shares of USANA Health Sciences by 2.1% in the third quarter. Martingale Asset Management L P now owns 16,732 shares of the company's stock worth $634,000 after buying an additional 340 shares in the last quarter. KBC Group NV lifted its position in shares of USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company's stock worth $40,000 after buying an additional 519 shares in the last quarter. R Squared Ltd purchased a new stake in shares of USANA Health Sciences in the fourth quarter worth about $28,000. Safe Harbor Fiduciary LLC purchased a new stake in USANA Health Sciences during the third quarter valued at approximately $30,000. Finally, Exchange Traded Concepts LLC raised its position in USANA Health Sciences by 11.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company's stock valued at $308,000 after purchasing an additional 869 shares during the period. 54.25% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research firms have issued reports on USNA. StockNews.com lowered USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. DA Davidson dropped their price objective on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research note on Thursday, February 27th. Finally, Sidoti lowered USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, February 18th.
Check Out Our Latest Stock Analysis on USNA
USANA Health Sciences Company Profile
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
